about
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reu...
Read More
3.87
-0.10
(-2.52%)
7,482.1
XNAS Volume
XNAS 21 Jul, 2026 12:16 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
NLS Pharmaceutics Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..